Can We Differentiate Pyelonephritis and Cystitis without 99mTc-Dimercaptosuccinic Acid Scan in Children?

Cilt: 40 Sayı: 3 30 Eylül 2015
Buket Kılıçaslan , Aytül Noyan , Nurcan Cengiz , Çağla Sarıtürk , Gönül Parmaksız , Esra Baskın
PDF İndir
EN TR

Can We Differentiate Pyelonephritis and Cystitis without 99mTc-Dimercaptosuccinic Acid Scan in Children?

Abstract

Purpose: Urinary tract infection is one of the most common infections in childhood. Because of the long term sequelae, differentiation of pyelonephritis from cystitis is important. The aim of this study is to determine the value of biomarkers such as C-reactive protein and procalcitonin and whether preferred to predict pyelonephritis in children without 99mTcDimercaptosuccinic Acid scan. Material and Methods: Fifty children aged 3 months to 16 years with a first urinary tract infection were included in this retrospective observational study. The medians, sensitivity, specificity, and cut-off values of serum C - reactive protein and procalcitonin to predict pyelonephritis were determined. Results: Thirty-two (64%) patients were diagnosed with pyelonephritis and 18 (36%) were diagnosed with cystitis. The cut-off value for C - reactive protein was 34 mg/L to predict pyelonephritis, with 69% sensitivity and 61% specificity. The cut-off value for procalcitonin was 0.23 ng/mL to predict pyehlonephritis, with 69% sensitivity and 66% specificity. In combination, these biomarkers were 63% sensitive and 78% specific to predict pyelonephritis. Conclusion: Using a combination of procalcitonin and C-Reactive Protein is preferred to predict pyelonephritis in children, instead of the 99mTc-Dimercaptosuccinic Acid scan. Because of its disadvantages, the 99mTcDimercaptosuccinic Acid scan should be avoided in children.

Keywords

Procalcitonin, Pyelonephritis, C - reactive protein

Kaynakça

  1. American Academy of Pediatrics. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics. 1999;103:843-52.
  2. Ammenti A, Cataldi L, Chimenz R, et al. Febrile urinary recommendations for the diagnosis, treatment and follow-up. Acta-Paediatr. 2012;10:451-7. children:
  3. Glauser MP, Lyons JM, Braude AI. Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. J Clin Invest. 1978;61:403-7.
  4. Bek K, Akman S, Bilge I, et al. Chronic kidney disease in children in Turkey. Pediatr Nephrol. 2009;24:797-806.
  5. Jodal U, Lindberg U. Guidelines for management of children with urinary tract infection and vesico- ureteral reflux. Recommendation from Swedish state of the art conference. Acta Paediatr. 1999;431:87-9.
  6. Rushton HG. The evaluation of acute pyhelonephritis and dimercaptosuccinic acid renal scintigraphy: evolving technetium 99m- in the emergency
  7. Ayazi P, Mahyar A, Hashemi HJ, et al. Comparison of procalcitonin and C-reactive protein tests in children with urinary tract infection. Iran J Pediatr. 2009;19:381-6.
  8. Güven AG, Kazdal HZ, Koyun M, et al. Accurate diagnosis of acute pyelonephritis: How helpful is procalcitonin? Nucl Med Commun. 2006;27:715-21.
  9. Tuerlinckx D, Borght TV, Glupczynski Y, et al. Is procalcitonin a good marker of renal lesion in febrile urinary tract infection? Eur J Pediatr. 2005;164:651-2.
  10. Bigot S, Leblond P, Foucher C, et al. Usefulness of procalcitonin for the diagnosis of acute pyelonephritis in children. Arch Pediatr. 2005;12:1075-80.

Kaynak Göster

MLA
Kılıçaslan, Buket, vd. “Can We Differentiate Pyelonephritis and Cystitis without 99mTc-Dimercaptosuccinic Acid Scan in Children?”. Cukurova Medical Journal, c. 40, sy 3, Ekim 2015, ss. 495-03, doi:10.17826/cutf.21897.